Press "Enter" to skip to content

Serum Institute of India rejects claims of serious side-effects of `Covishield` coronavirus vaccine by trial participant

image

New Delhi: The Serum Institute of India (SII) on Sunday (November 29, 2020) rejected the claims by a trial participant who alleged serious side-effects of ‘Covishield’ coronavirus vaccine. 

“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer,” said SII in a statement.

They added that the volunteer is falsely laying the blame for his medial problems on the COVID vaccine trial.

“The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent. In spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company,” stated the SII.

The world’s largest vaccine producer said it is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India said that they will seek damages in excess of Rs 100 crore for the same and will defend such malicious claims.

According to a PTI report, the man from Tamil Nadu has alleged that the candidate vaccine was not safe and claimed that he suffered from serious side effects including a virtual neurological breakdown and impairment of cognitive functions.

In a legal notice to the SII and others, he has sought a compensation of Rs 5 crore and also sought cancelling approval for its testing, ‘manufacture and distribution’, failing which legal action would be taken.

The notice alleged that the man suffered acute encephalopathy, damage or disease that affects the brain, following vaccination and all tests confirmed that the setback in his health was due to the test vaccine.

Source: Zee News